Health
Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein – DocWire News
Chimia (Aarau). 2021 May 28;75(5):446-452. doi: 10.2533/chimia.2021.446.ABSTRACTSerological testing for antibodies directed against SARS-CoV-2 in patients
Chimia (Aarau). 2021 May 28;75(5):446-452. doi: 10.2533/chimia.2021.446.
ABSTRACT
Serological testing for antibodies directed against SARS-CoV-2 in patients may serve as a diagnostic tool to verify a previous infection and as surrogate for an elicited humoral immune response, ideally conferring immunity after infection or vaccination. Here, we present the recombinant expression of an extended receptor binding domain (RBD) of the SARS-CoV-2 Spike protein used as capture antigen in a unique rapid…
-
Business24 hours ago10 high-conviction ASX dividend shares to buy for passive income today
-
Noosa News22 hours agoTrump’s trade war puts Australian beef centre stage in Shanghai
-
General21 hours agoCoomalie council dismissed by NT government after investigation finds ‘serious deficiencies’
-
Noosa News21 hours agoHuge suburban crowd cheers for luxury house sale at sausage sizzle auction